Edgewise Therapeutics, Inc.

Edgewise Therapeutics, Inc. - ROEverified

EWTX

Price:

$36.81

Market Cap:

$3.96B

Edgewise Therapeutics, Inc. is a biopharmaceutical firm dedicated to developing small-molecule treatments for a range of musculoskeletal disorders. Its leading investigational drug, EDG-5506, is an orally administered compound specifically engineered to tackle the fundamental genetic causes of dystrophinopathies, including Duchenne and Becker muscular dystrophy. This candidate has successfully concluded its Phase 1 clinical trial. Beyond EDG-5506, Edgewise maintains a pipeline of precision medicine candidates designed to modulate key muscle proteins, thereby addressing various genetically defined muscle conditions. Established in 2017, the company is headquartered in Boulder, Colorado.

Industry

Biotechnology

IPO Date

2021-03-26

Stock Exchange

NASDAQ

Ticker

EWTX

The ROE as of June 2026 (TTM) for Edgewise Therapeutics, Inc. (EWTX) is -32.55%

According to Edgewise Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -32.55%. This represents a change of 294.95% compared to the average of -8.24% of the last 4 quarters.

Edgewise Therapeutics, Inc. (EWTX) Historical ROE (quarterly & annually)

How has EWTX ROE performed in the past?

The mean historical ROE of Edgewise Therapeutics, Inc. over the last ten years is -2.93%. The current -32.55% ROE has changed 1.01% with respect to the historical average. Over the past ten years (40 quarters), EWTX's ROE was at its highest in in the December 2020 quarter at 18.98%. The ROE was at its lowest in in the March 2020 quarter at -13.61%.

Quarterly (TTM)
Annual

Average

-2.93%

Median

-19.51%

Minimum

-32.13%

Maximum

56.29%

Edgewise Therapeutics, Inc. (EWTX) ROE by Quarter and Year

Discovering the peaks and valleys of Edgewise Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 61.03%

Maximum Annual ROE = 56.29%

Minimum Annual Increase = -130.58%

Minimum Annual ROE = -32.13%

Quarterly (TTM)
Annual
YearROEChange
2025-32.13%10.26%
2024-29.14%-7.25%
2023-31.42%61.03%
2022-19.51%25.03%
2021-15.60%-130.58%
202051.03%-9.34%

Edgewise Therapeutics, Inc. (EWTX) Average ROE

How has EWTX ROE performed in the past?

The current ROE of Edgewise Therapeutics, Inc. (EWTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-30.89%

5-year avg

-25.56%

10-year avg

-2.93%

Edgewise Therapeutics, Inc. (EWTX) ROE vs. Peers

How is EWTX’s ROE compared to its peers?

Edgewise Therapeutics, Inc.’s ROE is greater than Structure Therapeutics Inc. (-15.14%), greater than uniQure N.V. (-145.81%), greater than Viridian Therapeutics, Inc. (-60.70%), greater than Nuvation Bio Inc. (-44.10%), greater than Ocular Therapeutix, Inc. (-64.55%), greater than Mesoblast Limited (-14.02%), less than Galapagos N.V. (16.88%), greater than Janux Therapeutics, Inc. (-11.85%), greater than Celldex Therapeutics, Inc. (-50.72%), greater than Vera Therapeutics, Inc. (-74.86%),

Build a custom stock screener for Edgewise Therapeutics, Inc. (EWTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Edgewise Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Edgewise Therapeutics, Inc. (EWTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Edgewise Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Edgewise Therapeutics, Inc.'s ROE?

How is the ROE calculated for Edgewise Therapeutics, Inc. (EWTX)?

What is the highest ROE for Edgewise Therapeutics, Inc. (EWTX)?

What is the 3-year average ROE for Edgewise Therapeutics, Inc. (EWTX)?

What is the 5-year average ROE for Edgewise Therapeutics, Inc. (EWTX)?

How does the current ROE for Edgewise Therapeutics, Inc. (EWTX) compare to its historical average?